![Chronology of key trials evaluating dapagliflozin. Abbreviations: EF,... | Download Scientific Diagram Chronology of key trials evaluating dapagliflozin. Abbreviations: EF,... | Download Scientific Diagram](https://www.researchgate.net/publication/353902132/figure/fig1/AS:1056706020769792@1628949756664/Chronology-of-key-trials-evaluating-dapagliflozin-Abbreviations-EF-ejection-fraction.png)
Chronology of key trials evaluating dapagliflozin. Abbreviations: EF,... | Download Scientific Diagram
![JCM | Free Full-Text | The Impact of Novel Anti-Diabetic Medications on CV Outcomes: A New Therapeutic Horizon for Diabetic and Non-Diabetic Cardiac Patients JCM | Free Full-Text | The Impact of Novel Anti-Diabetic Medications on CV Outcomes: A New Therapeutic Horizon for Diabetic and Non-Diabetic Cardiac Patients](https://pub.mdpi-res.com/jcm/jcm-11-01904/article_deploy/html/images/jcm-11-01904-g001-550.jpg?1648866913)
JCM | Free Full-Text | The Impact of Novel Anti-Diabetic Medications on CV Outcomes: A New Therapeutic Horizon for Diabetic and Non-Diabetic Cardiac Patients
![rafavidalperez on Twitter: "More information coming DAPA ACT HF - TIMI 68 #HeartFailure @SOGACAR_ #ACorunaHF2021 https://t.co/JqXL2LOcRq" / Twitter rafavidalperez on Twitter: "More information coming DAPA ACT HF - TIMI 68 #HeartFailure @SOGACAR_ #ACorunaHF2021 https://t.co/JqXL2LOcRq" / Twitter](https://pbs.twimg.com/media/FBqx5_MXsAE7N0N.jpg)
rafavidalperez on Twitter: "More information coming DAPA ACT HF - TIMI 68 #HeartFailure @SOGACAR_ #ACorunaHF2021 https://t.co/JqXL2LOcRq" / Twitter
![rafavidalperez on Twitter: "More information coming DAPA ACT HF - TIMI 68 #HeartFailure @SOGACAR_ #ACorunaHF2021 https://t.co/JqXL2LOcRq" / Twitter rafavidalperez on Twitter: "More information coming DAPA ACT HF - TIMI 68 #HeartFailure @SOGACAR_ #ACorunaHF2021 https://t.co/JqXL2LOcRq" / Twitter](https://pbs.twimg.com/media/FBqxtmrUUAcd32Y.jpg)
rafavidalperez on Twitter: "More information coming DAPA ACT HF - TIMI 68 #HeartFailure @SOGACAR_ #ACorunaHF2021 https://t.co/JqXL2LOcRq" / Twitter
![rafavidalperez on Twitter: "More information coming DAPA ACT HF - TIMI 68 #HeartFailure @SOGACAR_ #ACorunaHF2021 https://t.co/JqXL2LOcRq" / Twitter rafavidalperez on Twitter: "More information coming DAPA ACT HF - TIMI 68 #HeartFailure @SOGACAR_ #ACorunaHF2021 https://t.co/JqXL2LOcRq" / Twitter](https://pbs.twimg.com/media/FBqzVHWVQAQ2tts.jpg)
rafavidalperez on Twitter: "More information coming DAPA ACT HF - TIMI 68 #HeartFailure @SOGACAR_ #ACorunaHF2021 https://t.co/JqXL2LOcRq" / Twitter
![Efficacy and safety of dapagliflozin in acute heart failure: Rationale and design of the DICTATE-AHF trial - ScienceDirect Efficacy and safety of dapagliflozin in acute heart failure: Rationale and design of the DICTATE-AHF trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0002870320303574-gr2.jpg)
Efficacy and safety of dapagliflozin in acute heart failure: Rationale and design of the DICTATE-AHF trial - ScienceDirect
![Sodium Glucose Cotransporter-2 Inhibition for Acute Myocardial Infarction: JACC Review Topic of the Week | Journal of the American College of Cardiology Sodium Glucose Cotransporter-2 Inhibition for Acute Myocardial Infarction: JACC Review Topic of the Week | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/50679703-e6c3-40c0-b508-a1597d38ad83/gr3.jpg)
Sodium Glucose Cotransporter-2 Inhibition for Acute Myocardial Infarction: JACC Review Topic of the Week | Journal of the American College of Cardiology
![rafavidalperez on Twitter: "More information coming DAPA ACT HF - TIMI 68 #HeartFailure @SOGACAR_ #ACorunaHF2021 https://t.co/JqXL2LOcRq" / Twitter rafavidalperez on Twitter: "More information coming DAPA ACT HF - TIMI 68 #HeartFailure @SOGACAR_ #ACorunaHF2021 https://t.co/JqXL2LOcRq" / Twitter](https://pbs.twimg.com/media/FBqzytiXIAINONj.jpg)